Please login to the form below

Not currently logged in
Email:
Password:

UK launches stem cell centre

King's College London is to set up a centre for stem cell and regenerative medicine

King's College London is set to launch the Centre for Stem Cells and regenerative medicine.

The centre, which will be based at Guy's Hospital in London, will bring together the cutting-edge stem cell research currently taking place across the College and its partner NHS trusts, as part of King's Health Partners. King's hopes to drive collaboration between scientists and clinicians through the centre, to translate the potential of stem cells into clinical reality for patients.

Professor Robert Lechler, vice-principal for Health at King's and executive director of King's Health Partners, said: "Our work at King's Health Partners, an Academic Health Sciences Centre, is focused on translating scientific research into clinical treatments for patients much faster. As the use of stem cells in regenerative medicine is emerging as a key priority for research in the UK, I am excited about what we can achieve through the Centre for Stem Cells & Regenerative Medicine at King's."

Professor Fiona Watt, former president of the International Society of Stem Cell Research, has been appointed as director of the centre, and from January 2012 will co-ordinate existing stem cell research at King's as well as establish her own research programme.

14th June 2011

From: Healthcare

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics